Please read and agree to the
terms and conditions
of this site.
I agree
Stream
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
europe blog main
europe top stories
2
×
fda
2
×
life sciences
national blog main
novartis
acute hepatic porphyria
alnylam pharmaceuticals
blackstone
boston
cancer
cardiometabolic disorders
clinical trials
clinical trials cushing's disease
cvc capital partners
deals
europe
givosiran
hereditary transthyretin amyloidosis
inclisiran
investing
jeff poulton
john maraganore
lumasiran
national institutes of health
national top stories
new york blog main
new york top stories
osilodrostat
pasireotide
patisiran
pcsk9 inhibitors
pitchbook
primary hyperoxaluria type 1
private equirty
rare disease
recordati
What
drug
rights
sold
2
×
ago
alnylam
approval
based
blackstone
cash
cushing’s
disease
disorder
drugs
fda
gaining
grab
inclisiran
italy
milestone
million
nabs
nod
novartis
pays
pharmaceuticals
potential
preclinical
rare
recordati
rnai
seven
stake
upfront
year
years
Language
unset
Current search:
fda
×
sold
×
" europe top stories "
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}